Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) announced the recent publication of a new scientific paper further supporting Hedgehog signaling pathway inhibition ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE